Kevin Fischbeck
Stock Analyst at B of A Securities
(3.89)
# 612
Out of 5,241 analysts
190
Total ratings
64.93%
Success rate
4.39%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kevin Fischbeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNC Centene | Upgrades: Buy | $34 → $60 | $59.15 | +1.44% | 14 | Apr 29, 2026 | |
| ELV Elevance Health | Upgrades: Buy | $405 → $435 | $402.27 | +8.14% | 5 | Apr 29, 2026 | |
| OPCH Option Care Health | Maintains: Buy | $32 → $35 | $20.86 | +67.79% | 2 | Dec 9, 2025 | |
| ACHC Acadia Healthcare Company | Downgrades: Underperform | $22 → $13 | $24.92 | -47.83% | 9 | Dec 3, 2025 | |
| ARDT Ardent Health | Maintains: Underperform | $12 → $10 | $9.80 | +2.04% | 4 | Nov 13, 2025 | |
| HUM Humana | Maintains: Neutral | $280 → $300 | $310.55 | -3.40% | 17 | Oct 10, 2025 | |
| UNH UnitedHealth Group | Maintains: Neutral | $350 → $390 | $389.24 | +0.20% | 27 | Oct 8, 2025 | |
| AMN AMN Healthcare Services | Maintains: Underperform | $20 → $18 | $26.92 | -33.14% | 5 | Sep 10, 2025 | |
| DVA DaVita | Maintains: Underperform | $145 → $140 | $194.61 | -28.06% | 13 | Sep 10, 2025 | |
| THC Tenet Healthcare | Maintains: Buy | $205 → $225 | $191.40 | +17.55% | 8 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $160 | $104.76 | +52.73% | 2 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $215 → $185 | $166.45 | +11.14% | 15 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $394 → $410 | $404.69 | +1.31% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $75 | $88.20 | -14.97% | 2 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $439 | $184.38 | +138.10% | 15 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6.5 | $10.35 | -37.20% | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.25 | $16.36 | -55.68% | 3 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $350 | $291.28 | +20.16% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $42 → $45 | $13.69 | +228.71% | 7 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.5 → $5.5 | $2.80 | +96.43% | 10 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $16.51 | +111.99% | 7 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $10 | $3.50 | +185.71% | 2 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7.5 | $13.10 | -42.75% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $23.01 | - | 3 | Sep 6, 2019 |
Centene
Apr 29, 2026
Upgrades: Buy
Price Target: $34 → $60
Current: $59.15
Upside: +1.44%
Elevance Health
Apr 29, 2026
Upgrades: Buy
Price Target: $405 → $435
Current: $402.27
Upside: +8.14%
Option Care Health
Dec 9, 2025
Maintains: Buy
Price Target: $32 → $35
Current: $20.86
Upside: +67.79%
Acadia Healthcare Company
Dec 3, 2025
Downgrades: Underperform
Price Target: $22 → $13
Current: $24.92
Upside: -47.83%
Ardent Health
Nov 13, 2025
Maintains: Underperform
Price Target: $12 → $10
Current: $9.80
Upside: +2.04%
Humana
Oct 10, 2025
Maintains: Neutral
Price Target: $280 → $300
Current: $310.55
Upside: -3.40%
UnitedHealth Group
Oct 8, 2025
Maintains: Neutral
Price Target: $350 → $390
Current: $389.24
Upside: +0.20%
AMN Healthcare Services
Sep 10, 2025
Maintains: Underperform
Price Target: $20 → $18
Current: $26.92
Upside: -33.14%
DaVita
Sep 10, 2025
Maintains: Underperform
Price Target: $145 → $140
Current: $194.61
Upside: -28.06%
Tenet Healthcare
Sep 10, 2025
Maintains: Buy
Price Target: $205 → $225
Current: $191.40
Upside: +17.55%
Sep 10, 2025
Maintains: Buy
Price Target: $145 → $160
Current: $104.76
Upside: +52.73%
Jul 16, 2025
Downgrades: Underperform
Price Target: $215 → $185
Current: $166.45
Upside: +11.14%
Jul 16, 2025
Downgrades: Neutral
Price Target: $394 → $410
Current: $404.69
Upside: +1.31%
Oct 2, 2024
Downgrades: Underperform
Price Target: $75
Current: $88.20
Upside: -14.97%
Apr 1, 2024
Downgrades: Underperform
Price Target: $439
Current: $184.38
Upside: +138.10%
Nov 8, 2023
Downgrades: Underperform
Price Target: $6.5
Current: $10.35
Upside: -37.20%
Nov 2, 2023
Downgrades: Neutral
Price Target: $7.25
Current: $16.36
Upside: -55.68%
Aug 4, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $291.28
Upside: +20.16%
Jun 2, 2023
Upgrades: Buy
Price Target: $42 → $45
Current: $13.69
Upside: +228.71%
Jun 15, 2022
Downgrades: Neutral
Price Target: $7.5 → $5.5
Current: $2.80
Upside: +96.43%
Jan 18, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $16.51
Upside: +111.99%
Jun 10, 2021
Downgrades: Underperform
Price Target: $10
Current: $3.50
Upside: +185.71%
Oct 8, 2020
Initiates: Underperform
Price Target: $7.5
Current: $13.10
Upside: -42.75%
Sep 6, 2019
Downgrades: Underperform
Price Target: n/a
Current: $23.01
Upside: -